Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Nakase H et al. |
Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21434949
|
Haagsma EB et al. |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848624
|
Ortiz de Frutos FJ |
[New horizons in the treatment of atopic dermatitis]. |
|
Allergol Immunopathol (Madr) |
pmid:11988144
|
Mori F et al. |
Increase of natural killer cells in children with liver transplantation-acquired food allergy. |
|
Allergol Immunopathol (Madr) |
pmid:29456038
|
Regueiro-GarcÃa A et al. |
Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. |
|
Allergol Immunopathol (Madr) |
pmid:29373243
|
Yamamoto M et al. |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. |
2007 |
Allergol Int |
pmid:17460441
|